CONTEXT THERAPEUTICS INC. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CONTEXT THERAPEUTICS INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2021-09-30 was $161.82K, a 425.09% increase year-over-year.
- CONTEXT THERAPEUTICS INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2021-06-30 was $119.36K, a 289.54% increase year-over-year.
- CONTEXT THERAPEUTICS INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2021-03-31 was $25.51K, a 79.91% decline year-over-year.
- CONTEXT THERAPEUTICS INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2020-09-30 was $30.82K.
- CONTEXT THERAPEUTICS INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2021 was $511.08K, a 133.11% increase from fiscal 2020.
- CONTEXT THERAPEUTICS INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2020 was $219.25K.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2021-12-31 | $511.08K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $161.82K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $119.36K 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $25.51K 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $219.25K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $30.82K 10-Q · filed 2021-12-02 | |
| 2020-06-30 | $30.64K 10-Q · filed 2021-12-02 | |
| 2020-03-31 | $126.97K 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |